Peripheral neuropathy in association with lymphoproliferative disorders such as multiple myeloma, chronic lymphocytic leukaemia and malignant lymphomas is well known.`1 Recent studies have shown that neuropathy also may occur in patients with monoclonal gammopathy of undetermined significance (MGUS), that is, without current signs of malignant lymphocytic or plasmocytic disease.5-Immunological studies have demonstrated in vivo binding of immunoglobulins to affected peripheral nerves ofthe same heavy and light chain types as those seen in the M-component in the circulating blood.79 10 The monoclonal immunoglobulins from patients with MGUS and neuropathy bind either to myelin of peripheral nerves or to connective tissue structures of the endoneurium. " 12 Serum monoclonal immunoglobulin from patients with MGUS and neuropathy has also been shown to induce experimental demyelination in the cat by intraneural injection. 13 Taken together these observations suggest that autoimmunological mechanisms play a role in the nerve destruction in patients with combined MGUS and neuropathy. From the fact that autoimmune disorders are linked to certain tissue types and genetic predisposition, a familial occurrence of combined MGUS and neuropathy would be expected. Consistent with this notion Bussis et al"4 recently reported the occurrence of peripheral neuropathy and paraproteinaemia of IgM in a mother and her son. This study reports coexisting peripheral neuropathy and IgM gammopathy in a brother and a sister.
Case reports Cases 1 and 2 were the 3rd and 5th child ofeight siblings born to healthy parents. One sister died at the age of 37 years from tuberculosis. Neither the deceased sister nor the healthy five other siblings had any known neurological disorder. However, it was not possible to examine the other siblings. Case I A white female was born 1916 with a congenital bilateral hip luxation and early development of bilateral hip arthrosis. At the age of 62 she had a sudden episode ofspeech disturbance and headache. A four vessel cerebral arteriogram was normal. She was treated with a thrombocytaggregation inhibitory agent for 6 years without any intervening transient cerebral ischaemic attacks. From the age of 68 she gradually noticed pricking and sticking sensations in the feet. One year later the paraesthesias had ascended to mid thigh and appeared in the finger tips. On examination at the age of 69 years in 1985 she had slight IgM monoclonal gammopathy and neuropathy in two siblings weakness of toes and feet but otherwise strength was normal. Both biceps jerks were depressed and the triceps, radial, knee and ankle jerks were all absent. There was a stocking loss for all sensory modalities. She had a slight intention tremor 16 The reagents were used at a dilution of 1:10. For identification of nerve elements in the skin specimens, skin sections were stained for neurofilament using a peroxidaseantiperoxidase technique. 7 Sera from the two patients were examined for immunoreactivity against components in peripheral nerves by an indirect immunofluorescence method. The sera in dilution 1:5 were applied to cryostat sections of human nerve specimens obtained at postmortem examination about 6 h after death. In addition the sera from the two siblings as well as sera from nine other patients with an IgM M protein but without peripheral neuropathy were examined for the presence of antibodies against bovine peripheral nerve myelin (PNM) with a slightly modified ELISA technique.18 Briefly, microtitre plates were coated with 0-1 ml/well of PNM (80 pg/ml) in 0 05 M sodium carbonate buffer (pH 9-6) and then incubated with sera. A concentration of 15 mg/l of IgM in each sample was used because it led to optimal discrimination between positive and negative controls. Controls were included on each plate and consisted of: (a) serum from a patient with previously detected high antibody activity against peripheral nerve and (b) pooled serum from 200 blood donors; and (c) serum from a patient with monoclonal gammopathy but without neuropathy. Controls were included on each plate. Alkaline phosphatase conjugated antihuman IgM antiserum (Sigma, St Louis, USA) was then applied. After washing and enzyme reaction was carried out the absorption was measured.
Results
Case I The sural nerve consisted of 10 fascicles with an endoneurial area of 0-67 mm.2 The total number of myelinated fibres was decreased to 1931 fibres (normal mean: 7,000 fibres) with a particular reduction of large myelinated fibres (fig 1) . Teased fibre preparation disclosed swelling and fragmentation ofmyelin into balls and ovoids and with multiple areas of segmental demyelination. Amyloid deposits and inflammatory cells were not seen. Immunohistological studies were not carried out on sural nerve specimens but direct immunofluorescence examination showed binding of IgM to nerve myelin in cutaneous nerves (fig 1) , whereas IgA, IgG or C3 complement did not bind. Indirect immunofluorescence showed binding of S-IgM to normal peripheral nerve myelin. Case 2 The sural nerve specimen showed a marked reduction of especially large myelinated fibres (fig 2) . Teased fibre analysis revealed segmental demyelination with swelling and fragmentation presenting as balls and ovoids of myelin. Amyloid deposits and inflammatory cell infiltration were not seen. (fig 4) . Sera from Case 1 and 2 contained antibodies against PNM as measured by ELISA. In contrast, in nine other patients with IgM monoclonal gammopathy (five patients with MGUS but no associated neuropathy, two patients with Waldenstrom's disease and one patient with a postinfectious neuropathy) there was no significant antibody activity in serum directed against PNM (table).
Discussion
Our two siblings had a benign IgM monoclonal gammopathy and an associated mixed axonal and demyelinating neuropathy, on account of electrophysiological and morphological criteria.
Immunopathological studies showed binding of IgM to nerve elements in skin in both patients and to sural nerve in one patient. These features are similar to previous reported neuropathies and IgM monoclonal gammopathies, in which an immunological mediated disorder has been suggested (for review see refs 6 8) . The finding of antibody activity against peripheral nerve tissue in the present two cases and the observation that their serum IgM immunostained normal peripheral nerves in vitro suggest that the M protein had autoantibody activity directed against peripheral nerve myelin. However, the pathological significance of these antibodies is not clear. 
